Myriad Genetics, Inc. · NASDAQ:MYGN
Vestal Point Capital, LP reported a 6.10% stake in Myriad Genetics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vestal Point Capital, LP reported a 6.10% stake in Myriad Genetics, Inc., 5,735,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 5,735,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 6.10% | 5,735,000 |
| Ryan Wilder | 6.10% | 5,735,000 |
Source
Related
- Myriad Genetics, Inc.
- Vestal Point Capital, LP
- Myriad Genetics, Inc. shareholders
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026